Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2012, Article ID 480529, 7 pages
http://dx.doi.org/10.1155/2012/480529
Research Article

Increased Urine IgM and IgG2 Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

1Department of Nephrology, Institution of Clinical Sciences, Lund University Hospital, 22185 Lund, Sweden
2Primary Care Unit, Capio-Citykliniken, Björkhemsvägen 15C, 29154 Kristianstad, Sweden
3Department of Cardiology, Danderyd Hospital, 18288 Stockholm, Sweden
4Department of Endocrinology, Malmö University Hospital, 20502 Malmö, Sweden
5Diabetes Centrum, Sahlgrenska University Hospital, 41345 Göteborg, Sweden
6Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital, 41345 Göteborg, Sweden
7Department of Endocrinology, Karolinska University Hospital, 17164 Solna, Sweden
8Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 18288 Stockholm, Sweden

Received 29 August 2011; Revised 8 November 2011; Accepted 22 November 2011

Academic Editor: Barbara Bartolini

Copyright © 2012 Ole Torffvit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ole Torffvit, Majid Kalani, Jan Apelqvist, et al., “Increased Urine IgM and IgG2 Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes,” Biochemistry Research International, vol. 2012, Article ID 480529, 7 pages, 2012. https://doi.org/10.1155/2012/480529.